SIGN UPLog In

Last deal

$37.4M

Amount

Venture - Series Unknown

Stage

16.11.2023

Date

2

all rounds

$54.9M

Total amount

General

About Company
EvolveImmune Therapeutics develops novel immunotherapies using its proprietary target discovery platform.

Industry

Sector :

Subsector :

Also Known As

BioCT

founded date

01.01.2018

Number of employees

1-10

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company is building a pipeline of therapeutic candidates for oncology and autoimmune diseases by identifying targets expressed on multiple immune cell types. EvolveImmune's platform aims to generate first-in-class treatments to address unmet needs in these areas.
Contacts

location

Westport, CT, USA

Phone number

Website URL

https://bioct.org/member/evolveimmune-therapeutics-inc/

Social url